Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Royal Sense Ltd announces the official launch of latest products in Pharmaceutical Category

Posted On: 2024-08-28 19:54:44 (Time Zone: IST)


Royal Sense Ltd has announced the launch of its new products Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale from August 28, 2024.

OPENTOP 40

Details: Pantoprazole 40 mg reduces stomach acid, treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor.

Description

Pantoprazole 40 mg is a medication primarily used to treat conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It belongs to a class of drugs known as proton pump inhibitors (PPIs), which work by blocking the proton pumps in the stomach lining that produce acid. This reduction in stomach acid helps alleviate symptoms like heartburn and promotes the healing of the esophagus and stomach lining. Pantoprazole is typically taken orally, usually once daily, and can be prescribed for both short-term and long-term use. Common side effects may include headaches, diarrhoea, and nausea. It is important to follow the dosage prescribed by a healthcare provider to minimise potential side effects.

OPENTOP D

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 10 mg improves gastrointestinal motility and reduces nausea and vomiting.

Description

Pantoprazole 40 mg and domperidone 10 mg are often used together to address gastrointestinal issues. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, treating conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome. By reducing acid, it helps heal the esophagus and stomach lining and alleviates symptoms such as heartburn. Domperidone is a prokinetic agent that enhances gastrointestinal motility and helps relieve nausea and vomiting by facilitating gastric emptying and improving coordination of stomach contractions. This combination can be particularly effective for managing symptoms associated with delayed gastric emptying and acid-related disorders. Common side effects include headaches and gastrointestinal disturbances, so it's essential to use these medications under medical supervision.

CEFIX 200

Details: Cefixime 200 mg is an oral antibiotic that treats bacterial infections like pneumonia, ear infections, and gonorrhea.

Description

Cefixime 200 mg is a broad-spectrum oral antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which work by inhibiting bacterial cell wall synthesis, thereby killing bacteria. Cefixime is effective against infections such as pneumonia, bronchitis, ear infections, throat infections, and urinary tract infections. It is also used for treating gonorrhea. The medication is typically taken once or twice daily, depending on the infection and the patient's condition. Common side effects include diarrhea, nausea, and abdominal pain. It's important to complete the full course of treatment as prescribed, even if symptoms improve, to prevent antibiotic resistance and ensure the infection is fully eradicated. Always follow a healthcare provider's instructions when using cefixime.

OPENTOP DSR

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 30 mg with delayed release property improves gastrointestinal motility and reduces nausea and vomiting for extended duration.

Description

Pantoprazole 40 mg is a combination medication that includes pantoprazole and domperidone. Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, helping to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Domperidone, a prokinetic agent, enhances gastrointestinal motility, reducing symptoms like nausea and vomiting. Together, they address both acid-related issues and digestive motility problems. Pantop DSR is commonly prescribed for patients experiencing symptoms related to excessive stomach acid and impaired digestion. It is usually taken orally, once daily, before meals. Common side effects may include headache, dry mouth, and gastrointestinal disturbances. It is essential to follow the prescribed dosage and consult a healthcare provider for proper usage.

OPENTOP L

Details: Opentop L combines pantoprazole 40mg and levosulpiride 75mg, reducing stomach acid and improving gastrointestinal motility, treating GERD and related symptoms.

Description:

Opentop L is a combination medication that includes pantoprazole and levosulpiride. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, effectively treating conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and ZollingerEllison syndrome. It helps in alleviating heartburn and promoting healing of the esophagus and stomach lining. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility, which helps relieve symptoms such as nausea, vomiting, and abdominal discomfort by improving the movement of the digestive tract. This combination addresses both excessive acid production and motility issues. Pantop L is typically prescribed for managing symptoms associated with acid reflux and digestive disturbances. Common side effects may include headache, gastrointestinal disturbances, and dizziness. Always follow the prescribed dosage and consult a healthcare provider for proper use.

Shares of Royal Sense Limited was last trading in BSE at Rs. 145.00 as compared to the previous close of Rs. 145.95. The total number of shares traded during the day was 6000 in over 3 trades.

The stock hit an intraday high of Rs. 145.00 and intraday low of 145.00. The net turnover during the day was Rs. 870000.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks

ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited

AGI Greenpac Ltd approves ~ Rs. 700 crore capex

NHPC Ltd updates on 300 MW Bikaner Solar Power Project

Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd

Trent Limited crosses operating portfolio of over 1000 fashion stores

Aditya Birla Capital Limited completes amalgamation of Aditya Birla Finance Limited

Cantabil Retail India Ltd opens 13 new showrooms

Kalpataru Projects International Ltd receives orders worth Rs. 621 crores

HCLTech elevates Public Sector expertise with launch of US subsidiary

India Glycols Limited adds 200 KLPD Ethanol capacity

FY 2024-25: Despite Supply Chain Woes, HAL Registers Revenue of Rs 30,400 Crores, Builds Capacities

Loyal Textile Mills Ltd sells part of its windmill units for Rs. 73.80 crores

Aditya Birla Real Estate Ltd streamlines portfolio - Divests Century Pulp and Paper undertaking for Rs. 3498 Cr

Artefact Projects Limited awarded project worth Rs. 241.63 lakh

Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI

Avenue Supermarts Ltd opens 3 new stores, increases store count to 415

Coastal Biotech Pvt Ltd starts trial runs at its Ethanol Plant

Walchandnagar Industries Limited receives contract worth Rs. 30.75 crores

GRSE Records 32 % YoY growth in the FY25

AGI Greenpac Limited to set up new Container Glass Plant in Madhya Pradesh

Triton Valves Limited signs contract with Robert Bosch GmBH

Jyoti Ltd to allot 59,63,636 shares to Rare Asset Reconstruction ltd

Avantel Ltd receives order worth Rs. 11.36 crores

Kohinoor Foods Ltd to sell rice factory for Rs. 190 crores as part of OTS

Aditya Vision Limited opens 4 showrooms at Jharkhand and UP

DCM Shriram Limited commissions new caustic soda flakes plant

Asian Granito India Limited receives IT demand notice

Newgen Software Inc. inks agreement for order worth USD 1,270,000

Blue Jet Healthcare Ltd receives demand notice from IT department for Rs. 1,93,38,55,250/- including interest

LTIMindtree announces strategic partnership with Google Cloud to drive Business Transformation with Agentic AI

NHPC commissions 3 units of Parbati-II HE project

ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings

Engineers India Ltd receives orders worth Rs. 245 crores

Blue Star appoints Mohit Sud as Group President, Unitary Cooling Products

Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21

HBL Engineering Limited receives Kavach contracts worth Rs. 762.56 crores

SPARC announces submission of IND Application for SBO-154 to USFDA

Hon'ble PM Shri Narendra Modi visits Solar Defence and Aerospace Ltd's facilities

Avenue Supermarts Ltd's store count increases to 412, opens 4 new stores today

Tera Software Ltd receives LOIs worth Rs. 273.2 crores from MVVNL

JSW Steel Ltd declared successful bidder by BCCL in the auction of Dugda Coal Washery in the State of Jharkhand

IRM Energy Ltd secures 5-Year RLNG supply agreement with Gujarat State Petroleum Corporation Limited

Uno Minda Strengthens Governance, appoints Ravi Mehra as Managing Director, and Expands Board Expertise

Manoj Vaibhav Gems 'N' Jewellers Ltd opens new Jewellery store at Narsipatnam

Income Tax Authority imposes penalty of Rs. 944.20 crore on InterGlobe Aviation Limited

Tejas Networks Ltd receives Rs. 189.1657 crore under PLI scheme

Nitco Ltd expects Rs. 100 crores on receipt of property from development of Leasehold Rights

Fusion Finance Limited fixes April 4, 2025 as record date for 55:91 rights issue

JM Financial Limited invests in rights issue of JM Financial Asset Management Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020